Author

Philomena Casey

Institution: Celgene (United States)

Observed institution: Celgene (United States)

OpenAlex ID: A5014840239

Efficacy and Safety of the Combination of Genasense™ (Oblimersen Sodium, Bcl-2 Antisense Oligonucleotide), Fludarabine and Rituximab in Previously Treated and Untreated Subjects with Chronic Lymphocytic Leukemia.

2005 · Blanche Mavromatis, Kanti R. Rai, et al. · Blood · 8

A Pilot Study of Genasense® (Oblimersen Sodium, Bcl-2 Antisense Oligonucleotide), Fludarabine and Rituximab in Previously Treated and Untreated Subjects with Chronic Lymphocytic Leukemia.

2004 · Asher Alban Chanan-Khan, Blanche Mavromatis, et al. · Blood · 6

Efficacy and Safety Of Pomalidomide Plus Low-Dose Dexamethasone In Advanced Multiple Myeloma: Results Of Randomized Phase 2 and 3 Trials (MM-002/MM-003)

2013 · David S. Siegel, Paul G. Richardson, et al. · Blood · 2

Works count: 3

Citation count: 16

H-index: 2

I10-index: